Konstantinos Ioannidis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Konstantinos Ioannidis has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Helen Giamarellou
1(st) Department of Internal Medicine & Infectious Diseases, Hygeia General Hospital, Athens, Greece
2 shared publications - Ilias Karaiskos
1(st) Department of Internal Medicine & Infectious Diseases, Hygeia General Hospital, Athens, Greece
2 shared publications - Lena E. Friberg
Department of Pharmacy Uppsala University Uppsala Sweden
2 shared publications A. Archontakis
1 shared publication- Aghavni Ginosyan
Department of Pharmacy, Uppsala University, Uppsala, Sweden
1 shared publication - Aikaterini Sakagianni
Intensive Care Unit, Sismanogleio General Hospital, Marousi, Greece
1 shared publication
Latest Publications
- 7 September 2026
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
Enhancing intravenous chemotherapy administration safety using parameterised smart infusion pumps: A one-year practice implementation
Objective: To standardise intravenous antineoplastic administration and reduce administration-phase discrepancies by implementing parameterised smart infusion pumps supported by a clinical pharmacist- governed drug library. Data Sources: Pump alert logs and structured clinical pharmacist records of administration discrepancies collected during routine care over 12 months following go-live. Data Summary: Chemotherapy administration is vulnerable to wrong infusion duration/rate selection and missed drug-specific requirements (e.g., in-line filters and light protection). A multidisciplinary team implemented parameterised smart infusion pumps with a structured library requiring selection of the exact antineoplastic agent prior to infusion. For each agent, validated infusion-time windows were mapped to safe rate ranges and enforced as locked hard limits; mandatory prompts highlighted filter and light-protection requirements where applicable. Clinical pharmacists led drug-library build, validation and change control with oncology/haematology physicians and nursing leadership, supported by staff training and standardised workflow aids. During the 12-month evaluation period, approximately 17,000 chemotherapy days and 40,000 chemotherapy infusions were assessed. Smart pump safeguards identified and enabled correction of 26 near-miss administration discrepancies before infusion initiation, corresponding to 0.15 discrepancies per 100 chemotherapy days. Parameterisation reduced programming steps and shortened set-up time by approximately 30 s per infusion, corresponding to an estimated net nursing time saving of around one hour per day. Conclusions: A clinical pharmacist-led parameterised smart pump programme strengthened standardisation at the point of administration and supported a proactive medication-safety culture in routine practice. This practice-based report provides transferable operational detail on governance and bedside safeguards for oncology pharmacy services.
- 7 September 2026
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
Enhancing intravenous chemotherapy administration safety using parameterised smart infusion pumps: A one-year practice implementation
Objective: To standardise intravenous antineoplastic administration and reduce administration-phase discrepancies by implementing parameterised smart infusion pumps supported by a clinical pharmacist- governed drug library. Data Sources: Pump alert logs and structured clinical pharmacist records of administration discrepancies collected during routine care over 12 months following go-live. Data Summary: Chemotherapy administration is vulnerable to wrong infusion duration/rate selection and missed drug-specific requirements (e.g., in-line filters and light protection). A multidisciplinary team implemented parameterised smart infusion pumps with a structured library requiring selection of the exact antineoplastic agent prior to infusion. For each agent, validated infusion-time windows were mapped to safe rate ranges and enforced as locked hard limits; mandatory prompts highlighted filter and light-protection requirements where applicable. Clinical pharmacists led drug-library build, validation and change control with oncology/haematology physicians and nursing leadership, supported by staff training and standardised workflow aids. During the 12-month evaluation period, approximately 17,000 chemotherapy days and 40,000 chemotherapy infusions were assessed. Smart pump safeguards identified and enabled correction of 26 near-miss administration discrepancies before infusion initiation, corresponding to 0.15 discrepancies per 100 chemotherapy days. Parameterisation reduced programming steps and shortened set-up time by approximately 30 s per infusion, corresponding to an estimated net nursing time saving of around one hour per day. Conclusions: A clinical pharmacist-led parameterised smart pump programme strengthened standardisation at the point of administration and supported a proactive medication-safety culture in routine practice. This practice-based report provides transferable operational detail on governance and bedside safeguards for oncology pharmacy services.
- Open Access
- 29 July 2026
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 67 (11) , 107946
An exploratory pharmacokinetic-pharmacodynamic analysis of ceftazidime-avibactam and various blood biomarkers in patients with hospital-acquired pneumonia or ventilator-associated pneumonia caused by Klebsiella pneumoniae
- 29 July 2026
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 67 (11) , 107946
Open AccessAn exploratory pharmacokinetic-pharmacodynamic analysis of ceftazidime-avibactam and various blood biomarkers in patients with hospital-acquired pneumonia or ventilator-associated pneumonia caused by Klebsiella pneumoniae
- 1 September 2016
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 48 (3) , 337-341
Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration
- 1 September 2016
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 48 (3) , 337-341
Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration
- 8 July 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (6) , 128
Endoscopic perineal prostatectomy: A new field for endoscopy
- 8 July 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (6) , 128
Endoscopic perineal prostatectomy: A new field for endoscopy
- 14 January 2012
- Published by Springer Nature in Obesity Surgery
- Vol. 22 (3) , 487-492
The Effects of Chronically Increased Intra-abdominal Pressure on the Rabbit Diaphragm
Diaphragmatic muscular remodeling is caused by various conditions and was mainly studied in pulmonary pathologies and chronic alterations of intra-thoracic pressure. We investigate the effect of the chronically increased intra-abdominal pressure (IAP) on the diaphragm by morphological and biochemical analysis. Thirty rabbits were divided into control and study groups. IAP was increased in group B to 12 mmHg for 2 months. The left hemidiaphragm underwent morphological, while the right underwent biochemical analysis. In H&E, all fibers were normal. ATPase analysis demonstrated that type I fibers show no differences between groups. Type ΙΙΑ were decreased (p = 0.016) while type ΙΙΒ/X fibers were increased (p = 0.025) in group B. Fibers with resistance to fatigue were decreased in group B (p = 0.024). In group B, biochemical activity for glutathione reductase (p = 0.004), glutathione peroxidase (p = 0.021), protein carbonylation (0.029), lipid peroxidation (p = 0.005), and balance of preoxidative–antioxidative factors (p = 0.006) was increased. Chronically increased IAP induces alterations to the rabbit diaphragm. Adaptation, equivalent to strenuous contraction, transforms the diaphragm to be functionally more efficient toward workload but makes it vulnerable against oxidative stress.
- 14 January 2012
- Published by Springer Nature in Obesity Surgery
- Vol. 22 (3) , 487-492
The Effects of Chronically Increased Intra-abdominal Pressure on the Rabbit Diaphragm
Diaphragmatic muscular remodeling is caused by various conditions and was mainly studied in pulmonary pathologies and chronic alterations of intra-thoracic pressure. We investigate the effect of the chronically increased intra-abdominal pressure (IAP) on the diaphragm by morphological and biochemical analysis. Thirty rabbits were divided into control and study groups. IAP was increased in group B to 12 mmHg for 2 months. The left hemidiaphragm underwent morphological, while the right underwent biochemical analysis. In H&E, all fibers were normal. ATPase analysis demonstrated that type I fibers show no differences between groups. Type ΙΙΑ were decreased (p = 0.016) while type ΙΙΒ/X fibers were increased (p = 0.025) in group B. Fibers with resistance to fatigue were decreased in group B (p = 0.024). In group B, biochemical activity for glutathione reductase (p = 0.004), glutathione peroxidase (p = 0.021), protein carbonylation (0.029), lipid peroxidation (p = 0.005), and balance of preoxidative–antioxidative factors (p = 0.006) was increased. Chronically increased IAP induces alterations to the rabbit diaphragm. Adaptation, equivalent to strenuous contraction, transforms the diaphragm to be functionally more efficient toward workload but makes it vulnerable against oxidative stress.